IDIBELL researchers identify the role of Notch signaling alterations in inducing blood aging, which manifests as myeloid skewing, reduced regenerative capacity and clonal expansion of old stem cells.
Notch signaling opens the way to a novel blood rejuvenating approach Read More »
Engarsertib is an oral molecule designed exclusively for the disease, able to significantly reduce severe nasal bleeding that can last for hours and forces repeated transfusions.
Researchers at IDIBELL-CSIC discover and film how cells that eliminate other dead cells “chew” them to fragment them.
A meeting to strengthen the link between academic training and clinical research to promote the future of biomedicine.
The blockade of an specific pseudogene in ovarian cancer reduces tumor growth without showing obvious signs of toxicity.
The winner was the THOR project, from IDIBELL, a universal and modular CAR-T therapy that allows the treatment of various tumors.
This is the first time in Spain and the second time in Europe that this bacterial resistance mechanism has been detected.
The exhibition Bellvitge, a la recerca del futur, opens promoted by IDIBELL
The study concludes that low levels of the enzyme caspase 3 in the donor increase the chances of dysfunction or rejection of the organ.
New advances on the oncogenic activity of FGFR1 mutations, highly present in pediatric glioma, the most common type of brain tumor in children.
Deciphering the FGFR1 oncogenic activity in glioma, a type of pediatric brain tumor Read More »
